Breaking News Instant updates and real-time market news.

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35

Astronics sees FY19 Aerospace revenue $710M-$745M

"In our third quarter press release, we revised our Aerospace segment revenue guidance for 2018 to $670 to $675 million, which we are affirming today. The midpoint of this range would show 26% growth over 2017," commented Peter J. Gundermann, President and CEO. He continued, "We are also issuing initial Aerospace segment revenue guidance for 2019 of $710 to $745 million, which suggests organic growth next year of approximately 6% to 11%. We are encouraged by our strong booking performance of $617 million in the first nine months of 2018, and the continued strength of our aerospace markets." Gundermann stated, "We are not issuing 2019 guidance today for our Test segment, given the pending sale and other developments in the business. We anticipate doing so by the end of the year. We have a backlog of $72 million, most of which is Aerospace and Defense, and are in negotiations for a large program expected to be worth $30 to $50 million, as previously announced. We expect the next 45 days will bring clarity about our Test segment in 2019." The Company also affirmed its Test segment review guidance of $120 million to $125 million for 2017. The Company expects to release its fourth quarter and full year 2018 financial results in late February 2019. FY18/FY19 revenue consensus $797.85M/$831.11M, respectively.

  • 14

    Nov

ATRO Astronics
$28.50

-0.13 (-0.45%)

05/10/18
ADAM
05/10/18
DOWNGRADE
Target $41
ADAM
Hold
Astronics downgraded to Hold at Canaccord
As reported previously, Canaccord analyst Ken Herbert downgraded Astronics to Hold from Buy. The analyst cited three reasons for his downgrade, including a lower reset of Aerospace margins, limited visibility in the test business, and incremental pressure on pricing as wide-body aircraft face further reductions in build rates. Herbert lowered his price target to $41 from $50 on Astronics shares.
05/10/18
ADAM
05/10/18
DOWNGRADE
ADAM
Hold
Astronics downgraded to Hold from Buy at Canaccord
02/27/18
RHCO
02/27/18
NO CHANGE
Target $39
RHCO
Hold
Astronics price target lowered to $39 from $48 at SunTrust
SunTrust analyst Michael Ciarmoli lowered his price target on Astronics to $39 after its "disappointing" Q4 earnings report, noting that a miss on top and bottom lines and affirmed FY18 outlook suggest that operating margins should trend lower and negate the positive tax impact. Ciarmoli keeps his Hold rating on Astronics, adding that its valuation discount of FY19 PE of 18.4-times relative to peer average of 21-times is warranted due to margin headwinds and FY18 risks.
01/12/18
ADAM
01/12/18
NO CHANGE
Target $48
ADAM
Buy
Astronics revenue inflection not reflected yet in stock, says Canaccord
Canaccord analyst Ken Herbert noted Astronics announced an increase in 2018 revenue guidance with an increase in both its Aerospace and Test businesses. The analyst believes both should be a positive and he said estimates will move higher to reflect the likely tax benefits and will provide an additional tailwind. He does not believe the revenue inflection point has been fully reflected in the stock yet. Herbert reiterated his Buy rating and raised his price target to $48 from $46 on Astronics shares.

TODAY'S FREE FLY STORIES

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.87

-0.055 (-2.86%)

16:50
08/23/19
08/23
16:50
08/23/19
16:50
Hot Stocks
Ra Medical Systems discloses NYSE notice related to 10-Q filing delay »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$35.73

-0.81 (-2.22%)

16:47
08/23/19
08/23
16:47
08/23/19
16:47
Syndicate
Breaking Syndicate news story on Pembina Pipeline »

Pembina Pipeline files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

APEN

Apollo Endosurgery

$3.50

(0.00%)

16:44
08/23/19
08/23
16:44
08/23/19
16:44
Syndicate
Breaking Syndicate news story on Apollo Endosurgery »

Apollo Endosurgery files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
08/23/19
08/23
16:40
08/23/19
16:40
General news
Fed's Clarida said the global economy has worsened »

Fed's Clarida said…

LQDA

Liquidia Technologies

$5.23

-0.38 (-6.77%)

16:35
08/23/19
08/23
16:35
08/23/19
16:35
Syndicate
Breaking Syndicate news story on Liquidia Technologies »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$175.24

-4.91 (-2.73%)

16:32
08/23/19
08/23
16:32
08/23/19
16:32
Hot Stocks
Visa CFO Prabhu sells over 25,000 class A common shares »

Visa vice chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 27

    Oct

QCOM

Qualcomm

$73.57

-3.55 (-4.60%)

16:31
08/23/19
08/23
16:31
08/23/19
16:31
Hot Stocks
Qualcomm CFO Dave Wise to retire, Akash Palkhiwala named interim CFO »

Qualcomm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

ANFI

Amira Nature Foods

$0.58

-0.0144 (-2.44%)

16:30
08/23/19
08/23
16:30
08/23/19
16:30
Hot Stocks
Amira Nature Foods receives NYSE notice over late Form 20-F filing »

Amira Nature Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/23/19
08/23
16:30
08/23/19
16:30
Options
Preliminary option volume of 26.7M today »

Preliminary option volume…

DXCM

DexCom

$173.45

-0.76 (-0.44%)

16:26
08/23/19
08/23
16:26
08/23/19
16:26
Hot Stocks
Court rules patents asserted against DexCom CGM systems are invalid »

The U.S. District Court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

  • 13

    Nov

CRM

Salesforce

$151.50

3.24 (2.19%)

, VMW

VMware

$133.43

-14.72 (-9.94%)

16:24
08/23/19
08/23
16:24
08/23/19
16:24
On The Fly
Fly Intel: Wall Street's top stories for Friday »

The stock market was…

CRM

Salesforce

$151.50

3.24 (2.19%)

VMW

VMware

$133.43

-14.72 (-9.94%)

PVTL

Pivotal Software

$14.86

1.17 (8.55%)

CBLK

Carbon Black

$26.05

1.525 (6.22%)

HAS

Hasbro

$104.16

-10.19 (-8.91%)

HPQ

HP Inc.

$17.81

-1.1 (-5.82%)

QCOM

Qualcomm

$73.57

-3.55 (-4.60%)

SBGI

Sinclair Broadcast

$43.10

-1.33 (-2.99%)

DIS

Disney

$131.70

-4.37 (-3.21%)

T

AT&T

$34.82

-0.57 (-1.61%)

QD

Qudian

$7.86

0.21 (2.75%)

INTU

Intuit

$278.53

2.48 (0.90%)

FL

Foot Locker

$34.00

-8 (-19.05%)

ATGE

Adtalem Global Education

$44.82

-6.11 (-12.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 10

    Sep

  • 10

    Sep

  • 11

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 10

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 12

    Dec

  • 16

    Dec

BMCH

BMC Stock Holdings

$24.79

-0.62 (-2.44%)

16:24
08/23/19
08/23
16:24
08/23/19
16:24
Syndicate
Breaking Syndicate news story on BMC Stock Holdings »

BMC Stock Holdings files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

MRVL

Marvell

$23.79

-1.01 (-4.07%)

16:20
08/23/19
08/23
16:20
08/23/19
16:20
Options
Five 5 minute put seller in Marvell Technology »

Five 5 minute put seller…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 10

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
08/23/19
08/23
16:20
08/23/19
16:20
Options
Closing CBOE SPX and VIX Index summary for August 23rd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:20
08/23/19
08/23
16:20
08/23/19
16:20
General news
Treasury Market Summary »

Treasury Market Summary:…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
08/23/19
08/23
16:17
08/23/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
08/23/19
08/23
16:16
08/23/19
16:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$1.29

-0.05 (-3.73%)

16:12
08/23/19
08/23
16:12
08/23/19
16:12
Syndicate
Breaking Syndicate news story on NantKwest »

NantKwest files $300M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.